MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$22,141K
Net loss
-$22,141K
Net income from
discontinued operations, net...
$11,081K
Net loss from
continuing operations
-$33,222K
Non-cash (loss) gain on
changes in fair value of...
$24,486K
Operating loss
-$8,439K
Accretion of interest and
amortization of discounts on...
$277K
Other expense, net
-$20K
Total operating
expenses
$8,439K
General and
administrative
$7,585K
Impairment of long-lived
assets
$854K
Back
Back
Income Statement
source: myfinsight.com
NovaBay Pharmaceuticals, Inc. (NBY)
NovaBay Pharmaceuticals, Inc. (NBY)